Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes outfoxed by GLP-1?

George G Holz1, Oleg G Chepurny

  • 1Department of Physiology and Neuroscience, New York University School of Medicine, New York, NY 10016, USA. holzg01@popmail.med.nyu.edu <holzg01@popmail.med.nyu.edu>

Science'S STKE : Signal Transduction Knowledge Environment
|January 27, 2005
PubMed
Summary

Glucagon-like peptide-1 (GLP-1) signaling in pancreatic beta cells promotes Foxo1 nuclear exclusion via protein kinase B (PKB). This mechanism may enhance beta-cell function and insulin secretion, benefiting type 2 diabetes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity.

Metabolism: clinical and experimental·2025
Same author

GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4.

General and comparative endocrinology·2025
Same author

Two GnRH-mitoxantrone Conjugates, Con-3 and Con-7, Target Endometrial Cancer Cells

Current molecular pharmacology·2025
Same author

Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells.

Molecules (Basel, Switzerland)·2024
Same author

Reductions of food intake and body weight in diet-induced obese rats following chronic treatment with a monomeric peptide multiagonist.

Clinical nutrition (Edinburgh, Scotland)·2024
Same author

Corrination mitigates peptide aggregation as exemplified for Glucagon.

Peptides·2023

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Foxo1 transcription factor activity is regulated by insulin/IGF-1 signaling pathways in pancreatic beta cells.
  • Phosphorylation of Foxo1 by protein kinase B (PKB) leads to nuclear exclusion and altered gene expression impacting cell growth.
  • The role of G protein-coupled receptors (GPCRs) in regulating Foxo1 activity via PI3K/PKB pathways is under investigation.

Purpose of the Study:

  • To investigate whether GPCRs, specifically for GLP-1, regulate Foxo1 activity in pancreatic beta cells.
  • To elucidate the signaling mechanisms by which GLP-1 influences Foxo1, PI3K, and PKB.
  • To understand how GLP-1 signaling contributes to beta-cell mass, insulin secretion, and glucose-lowering effects.

Main Methods:

  • Analysis of GLP-1 receptor activation effects on IRS-2, PI3K, and PKB in beta cells.

Related Experiment Videos

  • Investigating the role of PKB in mediating GLP-1-induced Foxo1 nuclear exclusion.
  • Review of signaling properties of GLP-1 relevant to beta-cell function and glucose homeostasis.

    • Main Results:

    • GLP-1 receptor activation significantly alters IRS-2, PI3K, and PKB activity in beta cells.
    • GLP-1 promotes Foxo1 nuclear exclusion through a PKB-dependent mechanism.
    • This pathway may lead to increased expression of PDX-1, a key regulator of beta-cell growth.

    Conclusions:

    • GLP-1 signaling pathway, involving PKB and Foxo1, is crucial for beta-cell function.
    • GLP-1's ability to increase beta-cell mass and insulin secretion may be mediated by Foxo1 nuclear exclusion.
    • Understanding this mechanism offers insights into therapeutic strategies for type 2 diabetes.